To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden

NCT00991419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: [18F]AZD4694

Sponsor

AstraZeneca